# A Phase 1, Open-Label Study of Intravenous Sildenafil in Patients With Cirrhosis

> **NCT01954524** · PHASE1 · TERMINATED · sponsor: **University of Maryland, Baltimore** · enrollment: 2 (actual)

## Conditions studied

- Cirrhosis

## Interventions

- **DRUG:** IV bolus injection of Sildenafil

## Key facts

- **NCT ID:** NCT01954524
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-05
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** The study is closed due to lack of funding to support the study.
- **Last updated:** 2022-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01954524

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01954524, "A Phase 1, Open-Label Study of Intravenous Sildenafil in Patients With Cirrhosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01954524. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*